Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Teva Plans To Take Skinny-Label Defeat To Supreme Court
Company Confirms It Will Seek Review Of GSK Labeling Carve-Outs Litigation In US
Feb 15 2022
•
By
David Wallace
Teva is seeking Supreme Court review of the litigation
More from Legal & IP
More from Generics Bulletin